HSHongli Sun

Hongli Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hongli Sun has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Li Lei

    Department of Surgery, Fifth Clinical College of Harbin Medical University, Daqing, 163316, P. R. China

    2 shared publications
  • Liu Yan

    Department of Pharmacology, Harbin Medical University, Harbin, 150081, P. R. China

    2 shared publications
  • Yonggang Cao

    Department of Pharmacology, Harbin Medical University-Daqing, Daqing, China

    2 shared publications
  • Bing Bai

    Wageningen Seed Science Centre, Laboratory of Plant Physiology, Wageningen University, 6708 PB Wageningen, The Netherlands

    1 shared publication
  • Cao Yong‐Gang

    Department of Pharmacology, Daqing Campus of Harbin Medical University, Daqing, 163319, P. R. China

    1 shared publication
  • Chu Wen‐Feng

    Department of Pharmacology, Harbin Medical University, Bio‐Pharmaceutical‐Engineering Key Laboratory of Heilongjiang Province‐Incubator of State Key Laboratory, Harbin, 150081, P. R. China

    1 shared publication

Latest Publications

  • Open Access

    The mechanism of neurogenic pulmonary edema in epilepsy

    by Hong Zhao, Guijun Lin, Mumu Shi, Jingquan Gao, Yanming Wang, Hongzhi Wang, Hongli Sun, Yonggang Cao


  • Open Access

    Crucial Role of Calcium-Sensing Receptor Activation in Cardiac Injury of Diabetic Rats

    by Hanping Qi, Yonggang Cao, Wei Huang, Yang Liu, Ye Wang, Lei Li, Lijuan Liu, Zhong Ji, Hongli Sun

    Cardiac injury is a common pathological change frequently accompanied by diabetes mellitus. Recently, some evidence indicated that calcium-sensing receptor (CaSR) expressed in the cardiac tissue. However, the functional role of CaSR in diabetic cardiac injury remains unclear. The present study was designed to investigate the relationship between CaSR activation and diabetes-induced cardiac injury. Diabetic model was successfully established by administration of streptozotocin (STZ) in vivo , and cardiomyocyte injury was simulated by 25.5 mM glucose in vitro . Apoptotic rate, intracellular calcium concentration ([Ca 2+ ] i ) and the expression of Bcl-2, Bax, extracellular signal-regulated protein kinase (ERK), c-Jun NH 2 -terminal protein kinase (JNK), and p38 were examined. We demonstrated a significant increase in left ventricular end-diastolic pressure (LVEDP) as well as decrease in maximum rate of left ventricular pressure rise and fall (±dp/dtmax), and left ventricular systolic pressure (LVSP), apoptosis of cardiomyocytes was also observed by TUNEL staining. In vitro , 25.5 mM glucose-induced apoptosis was detected by flow cytometry in neonatal rat cardiomyocytes. Further results showed that 25.5 mM glucose significantly increased [Ca 2+ ] i , up-regulated the expression of Bax, P-ERK and P-JNK, and suppressed Bcl-2 expression. However, the above deleterious changes were further confirmed when co-treatment with CaSR agonist GdCl 3 (300 µM). But the effects of GdCl 3 were attenuated by 10 µM NPS-2390, a specific CaSR inhibitor. When CaSR was silence by siRNA transfection, the effects of high glucose were inhibited. These results suggest that CaSR activation could lead to the apoptosis of cardiomyocytes in diabetic cardiac injury through the induction of calcium overload, the activation of the mitochondrial, and mitogen-activated protein kinase pathway.


  • Antiarrhythmic effects and ionic mechanisms of allicin on myocardial injury of diabetic rats induced by streptozotocin

    by Wei Huang, Ye Wang, Yong-Gang Cao, Han-Ping Qi, Lei Li, Bing Bai, Yang Liu, Hong-Li Sun

    The aim of this study was to evaluate the antiarrhythmic effect of allicin (AL) on streptozotocin (STZ)-induced diabetic rats and explore the possible mechanisms. Hyperglycemia was induced in rats by single intraperitoneal injection of STZ (40 mg/kg). Three days after STZ treatment, the hyperglycemic rats (plasma glucose levels ≥16.7 mM) were administered with AL (4, 8, and 16 mg/kg) by intraperitoneal injection daily for 28 days. The fasting blood glucose levels were measured on every seventh day during the 28 days of treatment. The body weight and blood glucose levels were detected after 28 days. Antiarrhythmic effect of AL was observed in the diabetic rats induced by BaCl2. To determine the ionic mechanism in rat ventricular myocytes of AL, action potential duration (APD), L-type calcium current (ICa-L), and inward rectifier potassium current (IK1) were recorded by the whole cell-patch clamp technique. The expressions of L-type calcium channel protein α1C mRNA and cell potassium channels protein Kir2.1 mRNA were studied by RT-PCR. AL normalized the RR interval and QT interval in diabetic rats. AL obviously delayed the onset of ventricular arrhythmia and reduced the score of arrhythmia induced by BaCl2. Electrophysiological experiment revealed that AL could shorten APD through inhibition of ICa-L and enhancement of IK1. RT-PCR analysis indicated that long-term treatment with AL could decrease the expression of α1C mRNA and increase the expression of Kir2.1 mRNA. AL has antiarrhythmic effect in STZ-induced diabetic rats. It is tempting for the application of AL to be a useful therapeutic approach in diabetes with ventricular arrhythmia.


  • Antiarrhythmic effects and ionic mechanisms of oxymatrine from Sophora flavescens

    by Cao Yong‐Gang, Jing Shan, Li Lei, Gao Jing‐Quan, Shen Zhi‐Ying, Liu Yan, Xing Yan, Wu Ming‐Li, Wang Ye, Xu Chang‐Qing, et al.

    Accumulating evidence indicates that oxymatrine may exert protective effects on the cardiovascular system. This study was designed to evaluate the antiarrhythmic effects as well as the electrophysiological properties of oxymatrine. The antiarrhythmic activity of oxymatrine was observed in a rat model of arrhythmia induced by coronary ligation. Action potential duration (APD), L‐type calcium current (ICa‐L), transient outward potassium current (Ito) and inward rectifier potassium current (IK1) in rat ventricular myocytes were recorded by utilizing the whole cell patch‐clamp technique. The results showed that administration of oxymatrine significantly delayed the onset of ventricular arrhythmia, decreased the duration of ventricular arrhythmia and reduced the arrhythmia score of arrhythmic rats. The beneficial effects of oxymatrine may be related to the shortening of APD through reduction of ICa‐L, enhancement of Ito and inhibition of IK1. Copyright © 2010 John Wiley & Sons, Ltd.


  • Cardioprotective effects and underlying mechanisms of oxymatrine against Ischemic myocardial injuries of rats

    by Sun Hong‐Li, Li Lei, Shang Lei, Zhao Dan, Dong De‐Li, Qiao Guo‐Fen, Liu Yan, Chu Wen‐Feng, Yang Bao‐Feng

    Oxymatrine has been demonstrated to have a variety of pharmacological actions. Accumulating evidence indicates that oxymatrine may exert a protective effect on the cardiovascular system. The study was designed to explore the possible role of oxymatrine against myocardial ischemic damage and several related signaling pathways as potential mechanisms. The protective properties of oxymatrine were studied in a rat model of acute myocardial infarction due to permanent ligation of the left anterior descending coronary artery. The results showed that administration of oxymatrine relieved myocardial injuries during ischemia, and this was achieved by protecting cardiomyocytes from apoptotic death. The beneficial effects of oxymatrine were likely mediated by an inhibition of lipid peroxidation (MDA production) and an increase in endogenous antioxidant activity (SOD), activation of the survival signaling molecule (Bcl‐2), and a reduction of apoptotic mediator (Fas) and intracellular Ca2+ overload. Copyright © 2008 John Wiley & Sons, Ltd.